Literature DB >> 9093616

Seroepidemiology of hepatitis B, C and delta viruses in Tunisia.

H Triki1, N Said, A Ben Salah, A Arrouji, F Ben Ahmed, A Bouguerra, S Hmida, R Dhahri, K Dellagi.   

Abstract

Serum samples from 33,363 healthy people in Tunisia have been tested for serological markers of hepatitis B, C and delta viruses (HBV, HCV and HDV). Hepatitis B surface antigen (HBsAg) was detected in 6.5% of sera. The overall seroprevalence of HBV was 37.5%. Vertical and perinatal transmission of HBV in the first 3 months of life occurred in only 0.4% of 177 mother and child pairs. HBV seroprevalence was 10.7% in infants under 5 years old and increased with age rapidly till 25 years of age and then more slowly in adulthood, reaching 54% for people aged over 40 years. HBsAg seropositivity varied throughout the country, ranging from 3% to 13% with higher prevalences in the south and central-west regions. Overall seroprevalences for HDV and HCV were 17.7% and 0.4%, respectively. HDV superinfection occurred later than HBV and increased with age in parallel with HBV. Overall, HCV and HBV infections had different geographical distributions throughout the country. The study confirmed the high prevalence of HBV infection in Tunisia; it occurs mainly in children and teenagers, and vertical and perinatal transmission of HBV does not appear to be significant. HDV superinfection is quite common in Tunisia and occurs in almost 44% of individuals infected with HBV. In contrast, seroprevalence of HCV in the Tunisian general population was low (0.4%). These results indicate differences in the distribution of the viruses and/or different routes of transmission.

Entities:  

Mesh:

Year:  1997        PMID: 9093616     DOI: 10.1016/s0035-9203(97)90374-6

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  24 in total

1.  Phylogenetic analysis of hepatitis C virus isolates from Tunisian patients.

Authors:  Ahlem Djebbi; Selma Mejri; Valerie Thiers; Henda Triki
Journal:  Eur J Epidemiol       Date:  2004       Impact factor: 8.082

Review 2.  Potential for human immunodeficiency virus parenteral transmission in the Middle East and North Africa: an analysis using hepatitis C virus as a proxy biomarker.

Authors:  Yousra A Mohamoud; F DeWolfe Miller; Laith J Abu-Raddad
Journal:  World J Gastroenterol       Date:  2014-09-28       Impact factor: 5.742

3.  Delta hepatitis within the Veterans Affairs medical system in the United States: Prevalence, risk factors, and outcomes.

Authors:  Tatyana Kushner; Marina Serper; David E Kaplan
Journal:  J Hepatol       Date:  2015-05-08       Impact factor: 25.083

4.  Hepatitis D infection: from initial discovery to current investigational therapies.

Authors:  Ben L Da; Theo Heller; Christopher Koh
Journal:  Gastroenterol Rep (Oxf)       Date:  2019-06-23

5.  First multicenter study for risk factors for hepatocellular carcinoma development in North Africa.

Authors:  Olfa Bahri; Sayeh Ezzikouri; Nissaf Ben Alaya-Bouafif; Fella Iguer; Abdallah Essaid El Feydi; Hafedh Mestiri; Moustapha Benazzouz; Tahar Khalfallah; Rajaa Afifi; Latifa Elkihal; Salah Berkane; Agnes Marchio; Nabil Debzi; Anne Dejean; Pascal Pineau; Hinda Triki; Soumaya Benjelloun
Journal:  World J Hepatol       Date:  2011-01-27

6.  Sudden hearing loss associated with peginterferon and ribavirin combination therapy during hepatitis C treatment.

Authors:  Hela Elloumi; Fatma Houissa; Najet-Bel Hadj; Dalila Gargouri; Malika Romani; Jamel Kharrat; Abdeljabbar Ghorbel
Journal:  World J Gastroenterol       Date:  2007-10-28       Impact factor: 5.742

7.  Serological and molecular expression of Hepatitis B infection in patients with chronic Hepatitis C from Tunisia, North Africa.

Authors:  Samar Ben Halima; Olfa Bahri; Nadia Maamouri; Imed Cheikh; Nissaf Ben Alaya; Amel Sadraoui; Ons Azaiez; Msaddak Azouz; Nabyl Ben Mami; Henda Triki
Journal:  Virol J       Date:  2010-09-15       Impact factor: 4.099

8.  Association of hepatitis C virus infection and diabetes in central Tunisia.

Authors:  Naoufel Kaabia; Elhem Ben Jazia; Ines Slim; Imen Fodha; Wissem Hachfi; Rafika Gaha; Mabrouk Khalifa; Aoutef Hadj Kilani; Halim Trabelsi; Ahmed Abdelaziz; Fethi Bahri; Amel Letaief
Journal:  World J Gastroenterol       Date:  2009-06-14       Impact factor: 5.742

9.  Prevalence of hepatitis d in the eastern mediterranean region: systematic review and meta analysis.

Authors:  Neda Amini; Seyed Moayed Alavian; Ali Kabir; Seyed Hossein Aalaei-Andabili; Seyed Yasser Saiedi Hosseini; Mario Rizzetto
Journal:  Hepat Mon       Date:  2013-01-06       Impact factor: 0.660

10.  Prevalence and risk factors of hepatitis B and C virus infections among the general population and blood donors in Morocco.

Authors:  Warda Baha; Abderrahim Foullous; Noureddine Dersi; Thierry Paluku They-they; Khadija El alaoui; Nadia Nourichafi; Bouchra Oukkache; Fatiha Lazar; Soumaya Benjelloun; My Mustapha Ennaji; Abdelouhad Elmalki; Hassan Mifdal; Abdelouaheb Bennani
Journal:  BMC Public Health       Date:  2013-01-18       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.